Premium
Peer Review Certifies Quality and Innovation in Clinical Pharmacology & Therapeutics
Author(s) -
Waldman SA,
Terzic A
Publication year - 2017
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt.763
Subject(s) - audience measurement , dissemination , quality assurance , quality (philosophy) , medicine , pharmacology , knowledge management , computer science , business , pathology , telecommunications , philosophy , external quality assessment , epistemology , advertising
Clinical Pharmacology & Therapeutics (CPT) is an established voice of the discipline, a trusted source of new knowledge showcasing discovery, translation, and application of novel therapeutic paradigms to advance the management of patients and populations. Identifying, evaluating, prioritizing, and disseminating the best science along the discovery–development–regulatory–utilization continuum are responsibilities shared through peer review. To enhance the uniformity of this essential component of quality assurance and innovation, and maximize the value of the journal and its contents to authors, reviewers, and the readership, we review key concepts concerning peer review as it specifically relates to CPT.